The trajectory of individual ADC targets in lung cancer is reviewed, the latest clinical trial results are described, and future innovations in ADC therapies and potential mechanisms of resistance are discussed.
Henry Pickett, J. Arias-Romero, Jeremy Fricke et al.· Trends in Cancer· 0 citations
A multidisciplinary panel of oncology experts convened to review current evidence gaps, controversies, and unmet needs in the management of lung cancer, highlighting the need for prospective, head‐to‐head clinical trials.
N. Florez, S. Patel, R. Salgia et al.· Cancer· 1 citation
Current AI applications in lung cancer related to radiologic imaging, digital pathology, genomics, immunohistochemistry, and Cell Painting morphology are examined and their potential to be incorporated into a proposed multimodal model is examined.
T. Chakrabarti, A. Mansour, Xi-Wei Wu et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.